Overview

Description

  • NatureSynthetic

Specifications

Our Abpromise guarantee covers the use of ab4991 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

  • Applications

    Blocking

  • FormLiquid
  • Additional notes


    This peptide may be used for neutralization and control experiments with the polyclonal antibody that reacts with this product and human KChIP 2, catalog ab3473. Using a solution of peptide of equal volume and concentration to the corresponding antibody will yield a large molar excess of peptide (~ 70-fold) for competitive inhibition of antibody-protein binding reactions.

  • Concentration information loading...

Preparation and Storage

  • Stability and Storage

    Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C or -80°C. Avoid freeze / thaw cycle.

General Info

  • Alternative names
    • A type potassium channel modulatory protein 2
    • A-type potassium channel modulatory protein 2
    • Cardiac voltage gated potassium channel modulatory subunit
    • Cardiac voltage-gated potassium channel modulatory subunit
    • DKFZp566L1246
    • KChIP 2
    • KChIP2
    • KCIP2_HUMAN
    • KCNIP 2
    • Kcnip2
    • Kv channel interacting protein 2
    • Kv channel-interacting protein 2
    • MGC17241
    • Potassium channel interacting protein 2
    • Potassium channel-interacting protein 2
    see all
  • FunctionRegulatory subunit of Kv4/D (Shal)-type voltage-gated rapidly inactivating A-type potassium channels. Modulates channel density, inactivation kinetics and rate of recovery from inactivation in a calcium-dependent and isoform-specific manner. In vitro, modulates KCND2/Kv4.2 and KCND3/Kv4.3 currents. Involved in KCND2 and KCND3 trafficking to the cell surface. May be required for the expression of I(To) currents in the heart.
  • Tissue specificityExpressed in brain. Colocalizes with KCND2 in excitatory neurons including cortical and hippocampal CA1 pyramidal cells. Isoform 3 is expressed in heart and in umbilical vein endothelial cells. Not expressed in fetal heart.
  • Sequence similaritiesBelongs to the recoverin family.
    Contains 4 EF-hand domains.
  • Post-translational
    modifications
    Palmitoylated. Palmitoylation enhances association with the plasma membrane.
  • Cellular localizationCell membrane and Cell membrane. Detected on lipid rafts (By similarity).
  • Information by UniProt

References for KChIP2 peptide (ab4991)

ab4991 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab4991.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"